With USPTO Re-Exam Over, ExonHit and Jivan Likely to Resume Splice-Array Litigation
October 27, 2009
With USPTO Re-Exam Over, ExonHit and Jivan Likely to Resume Splice-Array Litigation
ExonHit said the conclusion of the reexamination paves the way for the resumption of the case between the two firms, both of which sell splice variant arrays and services.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Ariadne to Provide Pathway Analysis Instruction for Affy's Gene Expression Training Program
July 29, 2011 / BioInform - Kinexus Launches Proteomics Database Featuring 1.5M Phosphorylation Measurements
July 15, 2011 / ProteoMonitor - People In The News
July 1, 2011 / GenomeWeb Daily News - Affymetrix's Shares Jump 30 Percent in June to Lead GWDN Index
July 1, 2011 / GenomeWeb Daily News - IP Update
June 24, 2011 / BioInform